Systems and methods for injecting flowable materials into bones
A cavity creation device is introduced into a cancellous bone volume of a vertebral body through a percutaneous access path. The cavity creating device is manipulated to form a cavity in the cancellous bone volume. A volume of filling material is placed in the cavity by introducing a tube through the percutaneous access path and by conveying the filling material through a side dispensing port of the tube.
This application is a divisional of co-pending U.S. patent application Ser. No. 10/630,519, filed Jul. 30, 2003, and entitled “Systems and Methods for Injecting Flowable Materials Into Bone,” which is a divisional of U.S. patent application Ser. No. 09/893,298, filed Jun. 27, 2001 (now U.S. Pat. No. 6,645,213), which claims the benefit of provisional application Ser. No. 60/214,666 filed 27 Jun. 2000, and which is also a continuation-in-part of U.S. patent application Ser. No. 09/496,987, filed Feb. 2, 2000 (now U.S. Pat. No. 6,719,761), which is a divisional of U.S. patent application Ser. No. 08/910,809, filed Aug. 13, 1997 (now U.S. Pat. No. 6,048,346), each of which is incorporated herein by reference.
FIELD OF THE INVENTIONThe invention relates to the treatment of bone conditions in humans and other animals.
BACKGROUND OF THE INVENTIONSeveral companies offer mechanical bone cement injection devices. These devices are similar to a household caulking gun. Typically, the injection device has a pistol-shaped body, which supports a cartridge containing bone cement. The cement is typically in two-parts and must be mixed in a mixer and transferred into the cartridge for injection.
Just after mixing, and prior to curing, the cement is in a flowing, viscous liquid state, similar to a syrup or watery pancake batter in consistency. The injection device has a ram, which is actuated by a manually movable trigger or screwing mechanism for pushing the viscous bone cement out the front of the cartridge through a suitable nozzle and into the interior of a bone targeted for treatment.
Once injected into the targeted bone, the cement undergoes a curing cycle of perhaps 6 to 8 minutes. While curing, the cement passes from a viscous liquid to a putty-like consistency and finally to a hard rigid block.
SUMMARY OF THE INVENTIONThe invention provides, in its various aspects, greater control over the placement of cement and other flowable liquids into bone.
One aspect of the invention provides systems and methods for introducing a filling material into a the cancellous bone volume of a vertebral body. The systems and methods introduce a cavity creation device into the vertebral body through a percutaneous access path, and manipulate the cavity creating device to form a cavity in the cancellous bone volume. The systems and methods place a volume of filling material in the cavity through the percutaneous access path by providing a tube for conveying the filling material through the percutaneous access path. The tube has a distal end region sized and configured for placement within the cavity. The distal end region includes a sidewall and a side dispensing port in the sidewall. The volume of filling material is placed in the cavity by conveyance through the side dispensing port.
Features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended Claims.
The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTSThe illustrated embodiment shows the injector nozzle assembly 10 as part of a system 11, which injects cement for treating bone fracture or collapse, which is a purpose for which the assembly 10 is particularly well adapted. It should be appreciated, however, that the nozzle assembly 10 is not limited to use in the treatment of bone fractures or collapse.
In
As will be described in greater detail later, expansion of the body 20 creates a cavity in cancellous bone. The use of expandable bodies to treat bones in this fashion is disclosed in U.S. Pat. Nos. 4,969,888 and 5,108,404, which are incorporated herein by reference.
The nozzle assembly 10 is deployed into the formed cavity to dispense bone cement, as will also be described in greater detail later. The cement cures and hardens to provide renewed interior structural support for cortical bone surrounding the cancellous bone.
Further details of the injection nozzle assembly 10 will now be described.
I. The Injection Nozzle Assembly
The injection nozzle assembly 10 is intended to be component that can be removably connected to a conventional injection tool 14, e.g., by a threaded connector 36 (see
As
The injection tube 30 includes a center lumen 32. The nozzle assembly 10 also includes a distal dispensing end 34, through which the center lumen 32 extends.
In use (see
Because of the increasing viscosity (lessening flow) of the bone cement 38, it should preferably be injected within a few minutes following mixing. For this purpose, a ram rod 40 extends within the gun 22. The rod 40 carries a ram disk 44. The rod 40 is coupled to a finger trigger 42.
When the physician pulls the trigger 42 rearward (as arrow 43 shows in
Details of the gun 22 can be conventional and are not essential to the invention. The gun 22 can comprise a cement gun made, for example, by Stryker Corporation (Kalamazoo, Mich.). This particular gun has a manually operated trigger with a mechanical advantage of about 9 to 1. Other injection guns may be used, having more or less mechanical advantage. Non-manually operated injection guns can also be used.
The nozzle assembly 10 can be constructed in various ways. For example, the injector tube 30, including its dispensing end 34, can be made of a plastic material, such as polyethylene or other suitable polymer. The diameter and length of the nozzle assembly 10 will vary according to the nature of the procedure. For example, for delivering cement in the hip region, the nozzle assembly 10 can be about 10 to 30 cm long with an outer diameter of about 4 to 12 mm. For delivering cement to a vertebral body, the nozzle assembly 10 can be about 18 to 30 cm long with an outer diameter of about 3 to 8 mm in diameter.
A. Deflecting the Dispensing End
As
The deflection of the distal tube end 36 can be accomplished in various ways, which the following description exemplifies.
i. Fixed DeflectionIn the embodiment shown in
As will be described in greater detail later, the bias is overcome by passage of the dispensing end 34 through a guide sheath, which temporarily straightens the dispensing end 34 during its deployment in the intended treatment site. When free of the confines of the guide sheath, the bias returns the dispensing end 34 to its preestablished deflected condition.
ii. Adjustable DeflectionIn an alternative embodiment, as
In
Counterclockwise rotation of the wheel 56 (arrow direction A) pulls on the first steering wire 50, deflecting the dispensing end 34 upward (phantom line position 34A in
In an alternative embodiment (see
B. Cutting the Expelled Cement Bolus
i. Cutting WiresAs
As
In the embodiment shown in
As
Alternatively, the steering and cement cutting elements can be combined. For example, in the embodiment shown in
In
As
In use, while the distal stylet end 204 is withdrawn in the lumen 202, the cement bolus 62 is expressed from the central opening 32 of the dispensing end 34 (as
In this embodiment, the nozzle assembly 10 includes an injection tube 30 like that shown in
Unlike the embodiment shown in
As
As
As
Various constructions for the rotating fitting 104 are possible. In the illustrated embodiment, the rotating fitting 104 includes an adaptor 108 carried for rotation within the connector 36. The proximal end 110 of the injector tube 30 is secured to the adaptor 108 for common rotation. A retaining ring 112 outside the connector 36 surrounds tube 30, allowing its rotation but otherwise restraining rearward axial movement. An o-ring 114 is contained between the adaptor 108 and the end wall of the connector 36. The o-ring 114 restrains forward axial movement of the tube 30, while also preventing leakage of cement.
The rotating fitting 104 permits the physician to rotate the injection tube 30 with one hand, and thereby rotate the nozzle 34 (as arrows 106 show in
The rotating fitting 104 simplifies handling and manipulation of the cement injection tool 14 during rotation of the injection tube 30. The physician is able to rotate the injection tube 30, causing the one or more cement cutting loops carried by the rotating dispensing end 34 to cut loose an expelled cement bolus 62 (as shown in
As
For example, when the dispensing end 34 is normally biased in a deflected condition, as
The fitting 104 can also include additional auxiliary index marks (two of which 214 and 216 are shown in
The alignment of the index mark 212 with the index marks 210, 214, and 216 allows the physician to remotely orient the deflected end 34 in a desired way, without reliance upon x-ray or other internal visualization technique. Tracking the rotation of the index mark 212 relative to one or more of the index marks 210, 214, or 216 also allows the physician to gauge the rotation of the injection tube 30, to achieve the degree of rotation necessary to cut the cement bolus 62 loose.
When the dispensing end 34 is steerable (as shown in
When the dispensing end 34 includes a side dispensing port 180 (as shown in
C. Radiological Monitoring
In all the embodiments shown in
Other forms of markers can be used to allow the physician to visualize the location of the dispensing end 34 within the targeted treatment area.
II. Deployment of Nozzle Assembly in a Vertebral Body
Use of the nozzle assembly 10 will now be described when deployed in a human vertebra 150, which
The vertebra 150 includes a vertebral body 152, which extends on the anterior (i.e., front or chest) side of the vertebra 150. The vertebral body 152 includes an exterior formed from compact cortical bone 158. The cortical bone 158 encloses an interior volume of reticulated cancellous, or spongy, bone 160 (also called medullary bone or trabecular bone).
The vertebral body 152 is in the shape of an oval disk, which is generally symmetric about an anterior-posterior axis 154 and a mid-lateral axis 156. The axes 154 and 156 intersect in the middle region or geometric center of the body 152, which is designated MR in the drawings.
As
As
Expansion of the body 20 within the interior volume compresses cancellous bone 160 to form a cavity 164. The compaction of cancellous bone also exerts interior force upon cortical bone 158, making it possible to elevate or push broken and compressed bone back to or near its original prefracture position.
The body 20 is preferably left inflated for an appropriate waiting period, for example, three to five minutes, to allow coagulation inside the vertebral body 152. After the appropriate waiting period, the physician collapses the body 20 and removes it. As
As
If the dispensing end 34 is normally biased into a bent condition (as exemplified in
As shown in
As
As
As
Of course, the number and spacing of the markers 218 can vary. The markers 218 allow the physician to gauge when and to what extent the dispensing end 34 projects into the targeted site, without need for direct visualization.
Under radiologic visualization provided by the markers 68, the physician may rotate the injection tube 30. Rotation of the injection tube 30 orients the dispensing end 34 within the cavity 164 before or during the injection of cement 38. In the embodiment shown in
Alternatively, if the tube 30 carries one or more steering wires 50 and 52 (as exemplified in
As shown in
As
The physician observes the progress of the injection radiologically using the markers 68, positioning the dispensing end 34 by rotation or steering, or both, as just described.
The physician flows material 38 into the cavity 164, until the material 38 reaches the interior end of the guide sheath 166. If the dispensing end 34 carries one or more exterior loops (as exemplified in
In the embodiment shown in
As
The tool 12 is deployed through a guide sheath 166 in the portal 168 to form a cavity 172, in the same manner described above. The physician can manipulate the second tool 14 to steer the dispensing end 34 of the nozzle assembly 10 into the cavity 172. Although the transpedicular access portal aligns the tube 30 obliquely with respect to the axes 154 and 156, the deflected dispensing end 34 can be rotated into general alignment with either the anterior-posterior axis 154 or the mid-lateral axis 156 while injecting cement.
The deflected dispensing end 34 allows the introduction of cement 38 into the middle region MR of the vertebral body 152, using either postero-lateral access or a transpedicular access. The cement 28, when hardened, provides support uniformly across the middle region MR. The capability of the vertebral body 152 to withstand loads is thereby enhanced.
The above described procedure, carried out in a minimally invasive manner, can also be carried out using an open surgical procedure. Using open surgery, the physician can approach the bone to be treated as if the procedure is percutaneous, except that there is no skin and other tissues between the surgeon and the bone being treated. This keeps the cortical bone as intact as possible, and can provide more freedom in accessing the interior volume of the vertebral body 152.
III. Cooled Nozzle Assembly
After mixing and while curing, the cement 38 undergoes a chemical reaction that generates heat. When the cement temperature is below a given threshold value, the cement 38 maintains a flowing, viscous liquid state, which is suited for introduction through the nozzle assembly 10 into the targeted region. As the temperature increases beyond the threshold value, the cement 38 begins to harden, progressively losing its flow characteristic and becoming more resistant to passage through the nozzle assembly 10. It is desirable to expel the loose cement bolus 62 before the threshold temperature is reached.
The system 240 further includes at least one paired set of side lumens, which extend through the tube 30 axially beside the center lumen 30. In the illustrated embodiment (see
As best shown in
As
At the source 250, the cooling fluid is at a desired temperature, which is cooler than the threshold temperature of the cement 38. For example, the source fluid can comprise tap water at a temperature of about 68° F. (20° C.). While cement 38 is conveyed by the center lumen 32 for discharge, the pump 254 conveys cooling fluid from the source 250 through the inlet paths 242A, 244A, 246B, and 248B. The return paths 242B, 244B, 246B, and 248B carry the cooling fluid to waste 252. The circulation of cooling fluid in the tube 30 along the center lumen 32 dissipates heat generated by the curing cement 38, to mediate the temperature increase in the curing cement 38. The circulation of cooling fluid thereby keeps the curing cement 38 in the center lumen 32 in a viscous flowing condition for a longer period of time.
In the illustrated embodiment (see
It should be appreciated that the system 250 can also include a cutting element to sever the cement flow in response to rotation of the tube 30, as well as means for deflecting the dispensing end 34, in any of the manners previously described.
IV. Injector Nozzle Assembly With Variable Delivery Rates
As shown in
The syringe handle 306 and syringe body 304 can comprise, e.g., formed plastic or metal parts. The syringe handle 306 can be formed to possess different shapes and sizes. It is desired that the handle 306 is sized to fit comfortably in the hand of an operator.
The syringe body 304 can comprise a component that can be easily coupled to the handle 306 at time of use and then decoupled from the handle 306 and discarded after use. An o-ring 334 (see
A plunger advancement mechanism 312 is carried by the syringe handle 306, as
Desirably, the plunger advancement mechanism 312 is configured to accommodate different delivery objectives. For example, in a first delivery mode, the advancement mechanism 312 causes the syringe plunger 308 to advance or retract a set distance per rotation of a first actuator 314. In a second delivery mode, the advancement mechanism 312 causes the syringe plunger 308 to advance or retract at a different set distance per rotation of a second actuator 316.
In the illustrated embodiment, the first axial displacement is greater than the second axial displacement. The operator is thereby able to expel material 302 from the syringe body 304 in the first delivery mode more quickly per rotation of the actuator than in the second delivery mode. The operator can thereby easily switch from a relatively rapid, high volume discharge of flowable material, when so desired, to relatively slower, more metered, lower volume discharge of flowable material, when so desired. The operator is also able, in the first, high volume delivery mode, to rapidly retract the syringe plunger 308, to withdraw the pressure force of the syringe plunger 308 against the material 302, to thereby quickly terminate the flow of material from the syringe body 304. The ability to start and stop both large volume flow and metered, smaller volume flow makes it possible to rapidly respond to in situ flow conditions, to thereby prevent or minimize the flow of material 302 under pressure through cracks, openings, or voids in cortical bone, in a process called “extravazation.” The operation of the plunger advancement mechanism 312 to achieve a variable rate of delivery can be implemented in various ways. In the illustrated embodiment, the plunger advancement mechanism 312 responds to the application of rotational force to advance the syringe plunger 308. In this arrangement, rotatable first and second actuators or control knobs 314 and 316 are carried at the proximal end of the syringe handle 306. In use, the operator holds the syringe handle 306 in one hand, while applying force with the other hand to rotate either the first or second control knob 314 and 316. As
In the illustrated embodiment (see
The threaded slow advancement screw 318 is itself carried within the bore 322 of an externally threaded fast advancement screw 320. The exterior threads 324 of the slow advancement screw 318 engage interior threads 326 in the bore 322 of the fast advancement screw 320 (see
The fast advancement screw 320 is itself coupled to the first control knob 314, which is rotatably coupled to the syringe handle 306. The first control handle 314 includes an annular, internally threaded aperture 328 (see
In a representative embodiment, the exterior threads 324 of the slow advancement screw 318 comprise 10-degree modified right handed square threads (class 2G, single start), with sixteen threads to the inch. In this arrangement (see
Likewise, in a representative embodiment, the exterior threads 326 of the fast advancement screw 320 comprise 10-degree modified left handed square threads (class 2G, three start), with six threads to the inch. In this arrangement (see
As described, the plunger advancement mechanism 312 is operated manually. It should be appreciated that the plunger advancement mechanism can be operated by means of an electric motor or the like.
The assembly 300 shown in
In a representative embodiment, the syringe handle 306 (which can be made of polycarbonate) measures about 3.9 inches in length and 2.6 inches in width. The syringe body 304 (which also can be made of polycarbonate) measures about 5.1 inches in overall length, with an interior lumen having an inside diameter of about 0.5 inch.
In this representative embodiment, the first control knob 314 (which can be made from Celcon™ plastic material) is shaped round and has a diameter of about 2.5 inches. The fast advancement screw 320 (which can also be made from Celcon™ plastic material) has a length of about 4.5 inches and an outside thread diameter of about 0.75 inch. The internal threads extend for a distance of about 0.75 inch.
In this representative embodiment, the slow advancement screw 318 (which can also be made from Celcon™ plastic material) extends from the second control knob 316 for a length of about 9.35 inches and has an outside thread diameter of about ⅜ inch. The second control knob 316 is elliptical in shape, measuring about 2.0 inches along its major axis, about 0.625 inch along its minor axis, and about 1.5 inches in height.
The features and advantages of the invention are set forth in the following claims.
Claims
1. A system for creating a cavity in a vertebral body and injecting a flowable material into the cavity, comprising
- a tool for establishing a percutaneous access path to a vertebral body having a cortical wall enclosing a cancellous bone volume the tool having a distal end, a proximal end, and an inner diameter,
- a cavity creation device sized and configured for introduction into the vertebral body through a percutaneous access path to form a cavity in the cancellous bone volume, and
- a filling device sized and configured for placing a volume of filling material having a viscosity forming a bolus when expelled in the cavity through the percutaneous access path, the filling device comprising a tube for conveying the filling material through the percutaneous access path, the tube having a distal end region sized and configured for placement within the cavity and having an exterior surface permitting the distal end region to rotate within the cavity, the distal end region including a sidewall and a side dispensing port in the sidewall for conveying a volume of filling material into the cavity, wherein the distal end region includes a terminus that is closed such that the filling material can flow out of the filling device only from the side dispensing port, the side dispensing port having an edge shaped and structurally configured to sever a bolus of the filling material when the distal end region of the filling device is rotated within the cavity; and
- a filling material dispenser attachable to the filling device and configured to inject the filling material through the filling device and into the cavity in the vertebral body, wherein the filling device is rotatable relative to the filling material dispenser to permit the filling device to sever the bolus without rotating the filling material dispenser.
2. A system according to claim 1 wherein the distal end region is flexible.
3. A system according to claim 1 wherein the distal end region is deflectable.
4. A system according to claim 1 wherein the distal end region is steerable.
5. A system according to claim 1 wherein the cavity creation device comprises an expandable body.
6. A system according to claim 5 wherein the expandable body comprises a balloon.
7. A system according to claim 1, wherein the side dispensing port is a single port on a single side of the tube.
8. A system according to claim 1, wherein the tube has a proximal region extending toward the distal region along an axis, the distal region having a biased curve at an oblique angle from the axis.
9. A system according to claim 1, wherein the side dispensing port is sized for dispensing curable material and the tube has a continuous inner diameter at the distal end region.
10. A system according to claim 1, further comprising radiopaque markers disposed distally of the dispensing port in the distal end region of the tube, the radiopaque markers being visible during radioscopy to allow radiological visualization of the distal end region of the tube within the vertebral body.
11. A system according to claim 1, further comprising reference indicia on at least one of the injection tube and the filling material dispenser, the reference indicia indicating orientation or rotation of the injection tube.
3926705 | December 1975 | Todd |
4338925 | July 13, 1982 | Miller |
4551135 | November 5, 1985 | Gorman et al. |
4627434 | December 9, 1986 | Murray |
4653487 | March 31, 1987 | Maale |
4969888 | November 13, 1990 | Scholten et al. |
4976688 | December 11, 1990 | Rosenblum |
5108404 | April 28, 1992 | Scholten et al. |
5112305 | May 12, 1992 | Barath et al. |
5219897 | June 15, 1993 | Murray |
5231989 | August 3, 1993 | Middleman et al. |
5300048 | April 5, 1994 | Drewes, Jr. et al. |
5324273 | June 28, 1994 | Discko, Jr. |
5342325 | August 30, 1994 | Lun et al. |
5380276 | January 10, 1995 | Miller et al. |
5397304 | March 14, 1995 | Truckai |
5468245 | November 21, 1995 | Vargas, III |
5545136 | August 13, 1996 | Berger |
5562619 | October 8, 1996 | Mirachi et al. |
5569196 | October 29, 1996 | Muni et al. |
5571189 | November 5, 1996 | Kuslich |
5681317 | October 28, 1997 | Caldarise |
5704909 | January 6, 1998 | Morrey et al. |
5728066 | March 17, 1998 | Daneshvar |
5755797 | May 26, 1998 | Baumgartner |
5800409 | September 1, 1998 | Bruce |
5817057 | October 6, 1998 | Berenstein et al. |
5849014 | December 15, 1998 | Mastrorio et al. |
5972015 | October 26, 1999 | Scribner et al. |
5980504 | November 9, 1999 | Sharkey et al. |
6010449 | January 4, 2000 | Selmon et al. |
6019765 | February 1, 2000 | Thornhill et al. |
6048346 | April 11, 2000 | Reiley et al. |
6086594 | July 11, 2000 | Brown |
6113576 | September 5, 2000 | Dance et al. |
6348055 | February 19, 2002 | Preissman |
6383190 | May 7, 2002 | Preissman |
6395007 | May 28, 2002 | Bhatnagar et al. |
6412667 | July 2, 2002 | Huang |
6547432 | April 15, 2003 | Coffeen et al. |
6582446 | June 24, 2003 | Marchosky |
6592559 | July 15, 2003 | Pakter et al. |
6599293 | July 29, 2003 | Tague et al. |
6706069 | March 16, 2004 | Berger |
6719761 | April 13, 2004 | Reiley et al. |
6852095 | February 8, 2005 | Ray |
6979341 | December 27, 2005 | Scribner et al. |
34 43 167 | June 1986 | DE |
0 747 114 | December 1996 | EP |
2 338 428 | December 1999 | GB |
- Osteo-Site Bone Access Products, Cook Inc., 2002.
- Bone cement delivery engineered to your procedural needs, Ava-Tex Bone Cement Delivery System, CardinalHealth, 2003.
- SpinalSpecialties, Inc., 2003.
- SpinalSpecialties, Inc., Precise injection from outside the fluoro field, Osteoject Bone Cement Delivery System, Sep. 2002 Interpore Cross Internaitonal, Biologic & Structural Innovation, The CDO System, 2001.
- Office Action mailed Mar. 20, 2006 in U.S. Appl. No. 10/630,519, filed Jul. 30, 2003.
- Office Action mailed Oct. 5, 2007 in U.S. Appl. No. 10/630,519, filed Jul. 30, 2003.
- Office Action mailed Jan. 17, 2008 in U.S. Appl. No. 10/630,519, filed Jul. 30, 2003.
- Office Action mailed Aug. 27, 2008 in U.S. Appl. No. 10/630,519, filed Jul. 30, 2003.
- Office Action mailed Feb. 3, 2009 in U.S. Appl. No. 10/630,519, filed Jul. 30, 2003.
Type: Grant
Filed: Sep 27, 2006
Date of Patent: Apr 27, 2010
Patent Publication Number: 20070055279
Assignee: Kyphon SÀRL (Neuchatel)
Inventors: Paul M Sand (San Carlos, CA), Mark A Reiley (Piedmont, CA), Arie Scholten (Manteca, CA), Robert M Scribner (Niwot, CO), Michael L Reo (Redwood City, CA)
Primary Examiner: Pedro Philogene
Attorney: Haynes and Boone, LLP
Application Number: 11/528,160
International Classification: A61B 17/58 (20060101);